Global Companion Diagnostics Market Analysis & Trends Report 2016 - Industry Forecast to 2025 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Companion Diagnostics Market Analysis & Trends - Industry Forecast to 2025" report to their offering.

The Global Companion Diagnostics Market is poised to grow at a CAGR of around 18.5% over the next decade to reach approximately $16.24 billion by 2025.

This industry report analyzes the global markets for Companion Diagnostics across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025.

The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview

3.1 Current Trends

3.1.1 The field of companion diagnostics is picking up a lot of interest in the pharmaceutical and healthcare industry

3.1.2 Recent Techlological Developments of Companion Diagnostics

3.1.3 Growth Opportunities/Investment Opportunities

3.2 Drivers

3.3 Constraints

3.4 Industry Attractiveness

4 Companion Diagnostics Market, By Indication

4.1 Oncology

4.2 Cardiovascular conditions

4.3 Virology

4.4 Inflammation

4.5 CNS disorders

4.6 Other Indications

5 Companion Diagnostics Market, By Technology

5.1 Immunohistochemistry

5.2 Molecular diagnostics

6 Companion Diagnostics Market, By Application

6.1 Gastric Cancer

6.2 Breast Cancer

6.3 Lung Cancer

6.4 Melanoma

6.5 Colorectal Cancer

6.6 Other Applications

7 Companion Diagnostics Market, By End User

7.1 Hospitals

7.2 Reference Lab

7.3 Academic Medical Centers

7.4 Physicians

7.5 Pharmaceutical Companies

8 Companion Diagnostics Market, By Geography

9 Leading Companies

9.1 Abbott Laboratories

9.2 AstraZeneca

9.3 Biogenex Laboratories

9.4 Biomerieux Sa

9.5 Celera

9.6 Dako (Agilent Technologies)

9.7 Danaher Corporation

9.8 GE Healthcare

9.9 Genomic Health Inc.

9.10 Labcorp

9.11 Qiagen N.V.

9.12 Quest Diagnostics Inc.

9.13 Roche Diagnostics

9.14 Siemens

9.15 Thermo Fisher Scientific, Inc.

For more information visit http://www.researchandmarkets.com/research/7qm2k3/global_companion

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics, In Vitro Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics, In Vitro Diagnostics